For health care professionals

Important Safety Information

Make sure to tell your doctor if you have or have had congestive heart failure (CHF). Heart failure may happen in people who receive ZINPLAVA and can be serious. People with a history of CHF who received ZINPLAVA had a higher rate of heart failure and death than those who did not receive ZINPLAVA.

The most common side effects that may happen on the day of or the day after receiving ZINPLAVA are nausea, headache, fever, feeling tired, shortness of breath, feeling dizzy, and high blood pressure.

The most common side effects that may happen up to four weeks after receiving ZINPLAVA are nausea, fever, and headache.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the Patient Information for ZINPLAVA and discuss it with your doctor.
The physician Prescribing Information also is available.

Important Safety Information for ZINPLAVA (bezlotoxumab)

Make sure to tell your doctor if you have or have had congestive heart failure (CHF). Heart failure may happen in people who receive ZINPLAVA and can be serious. People with a history of CHF who received ZINPLAVA had a higher rate of heart failure and death than those who did not receive ZINPLAVA.

The most common side effects that may happen on the day of or the day after receiving ZINPLAVA are nausea, headache, fever, feeling tired, shortness of breath, feeling dizzy, and high blood pressure.

The most common side effects that may happen up to four weeks after receiving ZINPLAVA are nausea, fever, and headache.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the Patient Information for ZINPLAVA and discuss it with your doctor.
The physician Prescribing Information also is available.

Make sure to tell your doctor if you have or have had congestive heart failure (CHF).

Make sure to tell your doctor if you have or have had congestive heart failure (CHF). Heart failure may happen in people who receive ZINPLAVA and can be serious. People with a history of CHF who received ZINPLAVA had a higher rate of heart failure and death than those who did not receive ZINPLAVA.